A detailed history of Copperwynd Financial, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Copperwynd Financial, LLC holds 3,147 shares of TMO stock, worth $1.65 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
3,147
Previous 2,960 6.32%
Holding current value
$1.65 Million
Previous $1.64 Million 18.95%
% of portfolio
0.59%
Previous 0.51%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$531.86 - $624.21 $99,457 - $116,727
187 Added 6.32%
3,147 $1.95 Million
Q2 2024

Aug 15, 2024

BUY
$541.52 - $599.02 $192,781 - $213,251
356 Added 13.67%
2,960 $1.64 Million
Q1 2024

Apr 30, 2024

BUY
$528.82 - $599.43 $101,004 - $114,491
191 Added 7.92%
2,604 $1.51 Million
Q4 2023

Feb 13, 2024

BUY
$431.41 - $532.94 $58,240 - $71,946
135 Added 5.93%
2,413 $1.28 Million
Q3 2023

Nov 07, 2023

BUY
$498.29 - $574.41 $14,450 - $16,657
29 Added 1.29%
2,278 $1.15 Million
Q2 2023

Aug 08, 2023

BUY
$508.46 - $591.13 $24,914 - $28,965
49 Added 2.23%
2,249 $1.17 Million
Q1 2023

Apr 28, 2023

BUY
$535.0 - $604.82 $421,045 - $475,993
787 Added 55.7%
2,200 $1.27 Million
Q4 2022

Feb 02, 2023

SELL
$484.71 - $571.37 $23,266 - $27,425
-48 Reduced 3.29%
1,413 $778,000
Q3 2022

Nov 10, 2022

SELL
$507.19 - $604.49 $45,647 - $54,404
-90 Reduced 5.8%
1,461 $741,000
Q2 2022

Aug 05, 2022

SELL
$500.9 - $612.21 $15,527 - $18,978
-31 Reduced 1.96%
1,551 $842,000
Q1 2022

Apr 21, 2022

BUY
$524.0 - $644.92 $20,436 - $25,151
39 Added 2.53%
1,582 $934,000
Q4 2021

Feb 04, 2022

SELL
$569.0 - $667.24 $19,346 - $22,686
-34 Reduced 2.16%
1,543 $1.03 Million
Q3 2021

Nov 03, 2021

SELL
$509.53 - $609.78 $8,662 - $10,366
-17 Reduced 1.07%
1,577 $901,000
Q2 2021

Aug 12, 2021

BUY
$441.0 - $508.24 $13,671 - $15,755
31 Added 1.98%
1,594 $804,000
Q1 2021

May 06, 2021

SELL
$439.85 - $518.83 $51,902 - $61,221
-118 Reduced 7.02%
1,563 $713,000
Q4 2020

Feb 10, 2021

SELL
$435.06 - $527.66 $42,635 - $51,710
-98 Reduced 5.51%
1,681 $783,000
Q3 2020

Nov 05, 2020

SELL
$359.77 - $441.52 $27,702 - $33,997
-77 Reduced 4.15%
1,779 $785,000
Q2 2020

Aug 07, 2020

SELL
$275.2 - $362.34 $53,388 - $70,293
-194 Reduced 9.46%
1,856 $672,000
Q1 2020

May 11, 2020

SELL
$255.3 - $340.05 $62,548 - $83,312
-245 Reduced 10.68%
2,050 $581,000
Q4 2019

Jan 23, 2020

BUY
$271.93 - $328.04 $9,789 - $11,809
36 Added 1.59%
2,295 $745,000
Q3 2019

Nov 12, 2019

BUY
$268.46 - $305.43 $32,752 - $37,262
122 Added 5.71%
2,259 $663,000
Q2 2019

Aug 07, 2019

SELL
$257.51 - $295.55 $6,952 - $7,979
-27 Reduced 1.25%
2,137 $627,000
Q1 2019

May 13, 2019

BUY
$212.17 - $273.72 $2,970 - $3,832
14 Added 0.65%
2,164 $592,000
Q4 2018

Feb 08, 2019

SELL
$208.47 - $251.98 $18,553 - $22,426
-89 Reduced 3.97%
2,150 $481,000
Q3 2018

Nov 13, 2018

BUY
$205.57 - $244.32 $6,783 - $8,062
33 Added 1.5%
2,239 $546,000
Q2 2018

Aug 01, 2018

BUY
$203.14 - $219.53 $2,640 - $2,853
13 Added 0.59%
2,206 $457,000
Q1 2018

Apr 27, 2018

BUY
$192.98 - $224.11 $26,438 - $30,703
137 Added 6.66%
2,193 $453,000
Q4 2017

Feb 06, 2018

BUY
$182.03 - $200.37 $374,253 - $411,960
2,056
2,056 $390,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Copperwynd Financial, LLC Portfolio

Follow Copperwynd Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copperwynd Financial, LLC with notifications on news.